Myeloproliferative Neoplasms: Diagnosis, Treatment and Side Effect Management
Recorded on: December 11, 2024
Recorded on: December 11, 2024
1.90 CE Contact hours for nurses available until: August 18, 2026
1.50 CE Credits for social workers available until: August 18, 2026
1.90 CE Contact hours for nurse practitioners available until: February 28, 2026
Format: Non-interactive recorded webinar
Target Audience
Oncology nurse practitioners, nurses, and social workers involved in the care of patients with myeloproliferative neoplasms (MPNs).
Course content level for social workers: all levels
Description
This education program provides in-depth information about Myeloproliferative Neoplasms (MPNs). Participants will gain thorough understanding of MPNs, the latest tests and techniques used to diagnose MPNs, up-to-date treatment options and prognostic scoring systems, what the goals of treatment are, and strategies to manage side effects. The goal is to empower learners with the knowledge and resources needed to make informed decisions about treating MPNs and providing patient and family education and support.
Educational Objectives
After completing this activity, the participant should be better able to:
- Describe the types of myeloproliferative neoplasms, including myelofibrosis, polycythemia vera, and essential thrombocythemia (MPNs)
- Identify tests used to diagnose disease and monitor treatment of MPNs
- Explain the overarching goals of treatment for the various types of MPNS
- Explain approved and emerging treatment options for all MPNs, including stem cell transplantation, and the role of clinical trials
- Describe strategies to manage treatment side effects as well as potential long-term and late effects of treatments for MPNs
- Describe the healthcare professional’s role in managing patients with MPNs
Faculty
Carolanne Carini, MS, MSBSN, RN, BMTCN
Senior Nurse Coordinator, PAS
Memorial Sloan Kettering Cancer Center
New York, NY
Jacqueline Dela Pena, PharmD, BCOP
Clinical Pharmacy Specialist, Leukemia Service
Department of Pharmacy
Memorial Sloan Kettering Cancer Center
New York, NY
Michael Mauro, MD
Professor of Medicine
Director, Chronic Myeloid Leukemia Program
Leukemia Service
Memorial Sloan Kettering Cancer Center
New York, NY
Continuing Education Information
Nursing Continuing Professional Development
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society under Provider Number CEP 5832 to award 1.90 continuing education contact hours through the California Board of Registered Nursing.
Social Worker Continuing Education
The Leukemia & Lymphoma Society (LLS) Provider Number 1105, is approved as an ACE provider to offer social work continuing education by the Association of Social Work Boards (ASWB) Approved Continuing Education (ACE) program. Regulatory boards are the final authority on courses accepted for continuing education credit. ACE provider approval period: 12/10/2023-12/10/2026. Social workers completing this course receive 1.50 clinical continuing education credits.
The Leukemia & Lymphoma Society (LLS) is recognized by the New York State Education Departments State Board for Social Work as an approved provider of continuing education for licensed social workers #0117. LLS maintains responsibility for the program. Social workers will receive 1.50 clinical CE contact hours for this activity.
Nurse Practitioner Continuing Education
This activity is approved for 1.90 contact hour(s) of continuing education (which includes 0.55 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 25017047. This activity was planned in accordance with AANP Accreditation Standards and Policies.
Method of Participation
There are no fees for participating in or receiving credit for this CE activity. In order to receive credit, learners must participate in the entire CE activity, complete the activity posttest, evaluation form and your certificate of credit will be generated. A passing score of 70% or higher is needed to obtain credit.
If you have questions regarding your certificate, please contact Nicole Dane via email at ndane@kimeglobal.com.
Providers
This activity is provided by The Leukemia & Lymphoma Society.
Supporters
There is no commercial support associated with this CE activity.
Participants gain access to the webinar via the participation button above.
For questions, concerns, or for assistance for people with disabilities or grievances, please contact us at ProfEducation@LLS.org.